ERIC BJERKHOLT - Corporate Board Profile

CERUS CORP

Filing Date	Source Excerpt
2019-04-26	Eric Bjerkholt, 59, has served as a member of our Board since October 2018. Since April 2017, Mr. Bjerkholt has been the Chief Financial Officer of Aimmune Therapeutics, Inc., a biotechnology company developing treatments for food allergies. From 2004 until April 2017, Mr. Bjerkholt held various roles at Sunesis Pharmaceuticals, Inc., a biopharmaceutical company developing oncology therapeutics, including as Executive Vice President, Corporate Development and Finance and Chief Financial Officer. From 2002 to 2004, he was Senior Vice President and Chief Financial Officer at IntraBiotics Pharmaceuticals, Inc., a biopharmaceutical company that was acquired by Ardea Biosciences, Inc. in 2006. Mr. Bjerkholt was a co-founder of LifeSpring Nutrition, Inc., a nutraceutical company, and from 1999 to 2002 served at various times as its Chief Executive Officer, President, and Chief Financial Officer. From 1990 to 1997, he also served as a vice president in the healthcare banking group at J.P. Morgan & Co. Incorporated, an international banking firm. He has served on the boards of directors of several publicly traded companies, including as a member of the board of directors and chair of the audit committee of Corium International, Inc. until its acquisition by Gurnet Point Capital in November 2018, and as a member of the board of directors and as chair of the audit committee of StemCells, a biotech company, until its November 2016 acquisition by Microbot Medical Ltd. He holds a Cand. Oecon degree in Economics from the University of Oslo and an M.B.A. from Harvard Business School.
2020-04-24	Eric Bjerkholt, 60, has served as a member of our Board since October 2018. ... The Board has three standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. ... The following table provides membership and meeting information for fiscal 2019 for each of the Board committees: Eric Bjerkholt - Audit Committee. ... The following table shows for the fiscal year ended December 31, 2019 certain information with respect to the compensation of all non-employee directors of Cerus who served in such capacity during 2019. Eric Bjerkholt compensation: $66,000.
2021-04-23	Eric Bjerkholt, 61, has served as a member of our Board since October 2018... The Board removed Mr. Bjerkholt as a member and Chair of the Audit Committee in January 2021 after determining that Mr. Bjerkholt no longer qualified as independent... The Compensation Committee currently consists of four directors: Ms. Schulze (Chair), Dr. Witney, and Messrs. Swisher and Moore... The following table shows for the fiscal year ended December 31, 2020 certain information with respect to the compensation of all non-employee directors of Cerus who served in such capacity during 2020... Erik Bjerkholt Fees Earned or Paid in Cash($) 71,000, Option Awards($) 87,938, Stock Awards($) 84,262, Total($) 243,200.
2022-04-22	Eric Bjerkholt, 62, has served as a member of our Board since October 2018... The Audit Committee is currently composed of four directors: Dr. Witney (Chair), Ms. Lucena, Mr. Bjerkholt, and Mr. Swisher... The following table shows for the fiscal year ended December 31, 2021 certain information with respect to the compensation of all non-employee directors of Cerus who served in such capacity during 2021... Eric Bjerkholt: Fees Earned or Paid in Cash $51,355, Option Awards $83,674, Stock Awards $83,671, Total $218,700.
2023-04-28	Eric Bjerkholt, 63, has served as a member of our Board since October 2018. The Audit Committee is currently composed of four directors: Ms. Lucena (Chair), Dr. Witney, Mr. Bjerkholt, and Mr. Swisher.
2024-04-26	Eric Bjerkholt, 64, has served as a member of our Board since October 2018. ... Under our director compensation program in effect for 2023, each non-employee director was entitled to an annual grant of RSUs on the date of each of our annual meetings ... each of our non-employee directors other than Dr. Shan received an RSU grant covering 40,000 shares on the date of the 2023 Annual Meeting. ... The number of shares subject to the RSU awards was determined in 2023 by dividing the target dollar value ($200,000) by a price of $5.00 per share ... The aggregate grant date fair value of the annual RSU awards for 2023 granted on June 7, 2023, calculated in accordance with Topic 718 ... The total for Mr. Bjerkholt is $150,850.

Microbot Medical Inc.

Filing Date	Source Excerpt
2010-04-13	Eric Bjerkholt was elected to the Board of Directors in March 2004. He is Senior Vice President, Corporate Development and Finance, and Chief Financial Officer of Sunesis Pharmaceuticals, Inc. ... The Compensation Committee has been composed of Dr. Schwartz and Mr. Bjerkholt. ... The Audit Committee is composed of Mr. Bjerkholt and Drs. Schwartz and Levy. ... The following table summarizes compensation information for our non-employee directors ... Eric Bjerkholt: Total $54,019.
2011-05-17	Eric Bjerkholt was elected to the Board of Directors in March 2004. He is Senior Vice President, Corporate Development and Finance, and Chief Financial Officer of Sunesis Pharmaceuticals, Inc. ... Mr. Bjerkholt is a member of the board of directors of Round Table Pizza, Inc. ... The Audit Committee is composed of Mr. Bjerkholt and Drs. Schwartz and Levy. ... Mr. Bjerkholt is an audit committee financial expert. ... The following table shows the members of our four standing Board committees: Eric Bjerkholt - Chair of Audit Committee, member of Compensation and Strategic Transactions Committees. ... Director Compensation Table: Eric Bjerkholt Fees Earned in Cash $51,500, Stock Awards $11,800, Total $63,300.
2012-04-27	Eric Bjerkholt was elected to the Board of Directors in March 2004. He is Executive Vice President and Chief Financial Officer of Sunesis Pharmaceuticals, Inc. Mr. Bjerkholt is a member of the board of directors of Round Table Pizza, Inc. ... The Audit Committee is composed of Mr. Bjerkholt and Drs. Schwartz and Levy. ... The Compensation Committee is composed of Drs. Schwartz and Levy and Mr. Bjerkholt. ... The Corporate Governance Committee is composed of Drs. Levy, Perlmutter and Schwartz. ... The following table shows the members of our four standing Board committees: Eric Bjerkholt - Chair of Audit Committee, member of Compensation and Corporate Governance Committees. ... Director Compensation Table shows Eric Bjerkholt fees earned or paid in cash $53,500, Stock Awards $9,100, Total $62,600.
2013-10-31	The Audit Committee is composed of Mr. Bjerkholt and Drs. Schwartz and Levy. The Audit Committee held four meetings during the fiscal year ended December 31, 2012. ... Mr. Bjerkholt is an "audit committee financial expert," as defined in SEC rules. ... The Compensation Committee is composed of Drs. Schwartz and Levy and Mr. Bjerkholt. ... The Corporate Governance Committee is composed of Drs. Levy, Perlmutter and Schwartz. ... The following table shows the members of our four standing Board committees: Eric Bjerkholt - Chair Audit Committee, Compensation Committee, Corporate Governance Committee. ... Director Compensation Table: Eric Bjerkholt Fees Earned or Paid in Cash $52,500, Stock Awards $10,280, Total $62,780.
2014-04-30	Eric Bjerkholt was elected to the Board of Directors in March 2004. He is Executive Vice President and Chief Financial Officer of Sunesis Pharmaceuticals, Inc., a biopharmaceutical company. Mr. Bjerkholt is a member of the board of directors of Round Table Pizza, Inc. The Audit Committee is composed of Mr. Bjerkholt and Drs. Schwartz and Levy. The Audit Committee held five meetings during the fiscal year ended December 31, 2013. Each of the members of the Audit Committee is independent, and the Board has determined that Mr. Bjerkholt is an audit committee financial expert, as defined in SEC rules. The Audit Committee acts pursuant to a written charter which is available through our website at www.stemcellsinc.com. The Compensation Committee is composed of Drs. Schwartz and Levy and Mr. Bjerkholt. The Compensation Committee held eight meetings during the fiscal year ended December 31, 2013. The Corporate Governance Committee was composed of Drs. Levy and Schwartz and a former member of our Board of Directors, Dr. Roger Perlmutter, who resigned from our Board in December 2013. Following Dr. Perlmutter's resignation in December 2013, the Board appointed Mr. Greer to the Corporate Governance Committee. The following table shows the members of our four standing Board committees: Eric Bjerkholt - Chair of Audit Committee, member of Compensation Committee and Corporate Governance Committee. Director compensation table shows Eric Bjerkholt earned $74,500 in 2013.
2015-04-30	Eric Bjerkholt was elected to the Board of Directors in March 2004. He is Executive Vice President and Chief Financial Officer of Sunesis Pharmaceuticals, Inc., a biopharmaceutical company. Mr. Bjerkholt is a member of the board of directors of Ambrx, Inc. and Corium International, Inc. The Audit Committee is composed of Mr. Bjerkholt and Drs. Schwartz and Levy. The Audit Committee held four meetings during the fiscal year ended December 31, 2014. Each of the members of the Audit Committee is independent, and the Board has determined that Mr. Bjerkholt is an audit committee financial expert, as defined in SEC rules. The following table summarizes cash-based and equity compensation information for our outside directors for the year ended December 31, 2014: Eric Bjerkholt Fees Earned or Paid in Cash $54,250, Stock Awards $61,784, Total $116,034.
2016-04-08	Eric Bjerkholt was elected to the Board of Directors of StemCells, Inc. in March 2004. Mr. Bjerkholt chairs our Audit Committee. He is Executive Vice President, Corporate Development and Finance, and Chief Financial Officer of Sunesis Pharmaceuticals, Inc., a small molecule biopharmaceutical company. ... The following table summarizes cash-based and equity compensation information for our outside directors, including annual Board and committee retainer fees and meeting attendance fees, for the year ended December 31, 2015: ... Eric Bjerkholt Fees Earned or Paid in Cash $64,250, Stock Awards $60,000, Total $124,250.